Stay updated on Pembrolizumab in Recurrent HNSCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent HNSCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The study page gains a recruitment status update ('No longer looking for participants'), which directly affects enrollment. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision note to v3.6.0, while the prior revision note v3.5.5 is removed and the heading 'Intervention/Treatment' is adjusted.
    Difference
    0.4%
    Check dated 2026-06-12T14:25:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing v3.5.4. This indicates a small update to the page's metadata or formatting without altering the study details or data.
    Difference
    0.1%
    Check dated 2026-06-05T10:26:44.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, indicating a background update to the page's content/structure without changing the study details shown to users.
    Difference
    0.1%
    Check dated 2026-05-14T22:52:45.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The study record revision was updated to v3.5.3, representing a minor update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-04-30T14:36:52.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T10:45:06.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    Adds the disease topic 'Squamous cell carcinoma of the head and neck' and a Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T00:28:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent HNSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent HNSCC Clinical Trial page.